Evidence map›Paper›PMID 8613549›Full record

ArticleThe Journal of clinical investigation1996

Induction of Fanconi anemia cellular phenotype in human 293 cells by overexpression of a mutant FAC allele.

H Youssoufian, Y Li, M E Martin, M Buchwald

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 25 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

H YoussoufianDepartment of Medicine, Hematology-Oncology Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Y Li
M E Martin
M Buchwald
Harvard University · USUniversity of Toronto · CA

Funding

MOLECULAR ANALYSIS OF FANCONIS ANEMIA C PROTEINR01HL052138 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI PLON, SHARON EMMA · 1995 to 2003
$1.2M
NHLBI NIH HHS HL-52138
6 · The paper itself

Abstract

The polypeptide encoded by the Fanconi anemia (FA) complementation group C gene, FAC, binds to a group of cytoplasmic proteins in vitro and may form a multimeric complex. A known mutant allele of FAC resulting from the substitution of Pro for Leu at codon 554 fails to correct the sensitivity of FA group C cells to mitomycin C. We reasoned that overexpression of the mutant protein in a wild-type cellular background might induce the FA phenotype by competing with endogenous FAC for binding to the accessory proteins. After stable transfection of 293 cells with wild-type and a mutant FAC allele containing the L554P substitution, four independent clones that expressed four-to-fifteen fold higher levels of transcript from the mutant transgene relative to the endogenous FAC gene showed hypersensitivity to mitomycin C. By contrast, both parental and FAC-overexpressing cells maintained their relative resistance to mitomycin C. No differences in the biosynthesis, subcellular localization and protein interactions of the normal and mutant proteins were detected. The induction of the FA phenotype in this system is compatible with the competition hypothesis and provides support for a functional role of the FAC-binding proteins in vivo.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsNuclear ProteinsAllelesBase SequenceCell CompartmentationCells, CulturedCell SurvivalDNA PrimersFanconi AnemiaFanconi Anemia Complementation Group C ProteinFanconi Anemia Complementation Group ProteinsHumansMitomycinMolecular Sequence DataPhenotypeCell Cycle ProteinsDNA-Binding ProteinsDNA PrimersFANCC protein, humanFanconi Anemia Complementation Group C ProteinFanconi Anemia Complementation Group ProteinsMitomycinNuclear ProteinsProteinsRecombinant Proteins

Identifiers

PMID8613549
PMCPMC507141
OpenAlexW2054965243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.